Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Retinoic Acids Repress Constitutive Active Receptor-Mediated Induction by 1,4-bis[2-(3,5-Dichloropyridyloxy)]benzene of theCyp2b10 Gene in Mouse Primary Hepatocytes

Satoru Kakizaki, Sohrab Karami and Masahiko Negishi
Drug Metabolism and Disposition February 2002, 30 (2) 208-211; DOI: https://doi.org/10.1124/dmd.30.2.208
Satoru Kakizaki
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sohrab Karami
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masahiko Negishi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 30 no. 2 208-211
DOI 
https://doi.org/10.1124/dmd.30.2.208
PubMed 
11792692

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received July 31, 2001
  • Accepted November 9, 2001
  • Published online February 1, 2002.

Copyright & Usage 
U.S. Government

Author Information

  1. Satoru Kakizaki,
  2. Sohrab Karami and
  3. Masahiko Negishi
  1. Pharmacogenetics Section, Laboratory of Reproductive and Developmental Toxicology, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina
  1. Dr. Satoru Kakizaki, Pharmacogenetics Section, Laboratory of Reproductive and Developmental Toxicology, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina 27709. E-mail: kakizaki{at}niehs.nih.gov
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to September 2023

AbstractFullPdf
Aug 2017070
Sep 20170124
Oct 20170141
Nov 20171172
Dec 20170122
Jan 2018081
Feb 20182114
Mar 20181112
Apr 20180152
May 20180134
Jun 20181172
Jul 2018042
Aug 20180131
Sep 2018092
Oct 20180104
Nov 2018070
Dec 2018653
Jan 2019500
Feb 2019710
Mar 20191310
Apr 20191300
May 2019832
Jun 2019822
Jul 20191100
Aug 2019921
Oct 20191110
Nov 20191900
Dec 20191500
Jan 20201400
Feb 20203100
Mar 2020800
May 20201200
Jun 20201700
Jul 2020600
Aug 2020220
Sep 2020300
Oct 2020900
Nov 20201110
Dec 20201421
Jan 20212042
Feb 2021542
Mar 20211321
Apr 20211021
May 20211031
Jun 2021720
Jul 20211620
Aug 20211350
Sep 2021530
Oct 2021410
Nov 2021810
Dec 20212010
Jan 2022810
Feb 2022210
Mar 2022710
Apr 20221020
May 2022421
Jun 2022921
Jul 20221220
Aug 20221030
Sep 2022510
Oct 20221330
Nov 20221720
Dec 2022700
Jan 20232410
Feb 2023765
Mar 20232154
Apr 20231163
May 20231874
Jun 2023466
Jul 20231931
Aug 2023420
Sep 2023810

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 30 (2)
Drug Metabolism and Disposition
Vol. 30, Issue 2
1 Feb 2002
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Retinoic Acids Repress Constitutive Active Receptor-Mediated Induction by 1,4-bis[2-(3,5-Dichloropyridyloxy)]benzene of theCyp2b10 Gene in Mouse Primary Hepatocytes
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Retinoic Acids Repress Constitutive Active Receptor-Mediated Induction by 1,4-bis[2-(3,5-Dichloropyridyloxy)]benzene of theCyp2b10 Gene in Mouse Primary Hepatocytes

Satoru Kakizaki, Sohrab Karami and Masahiko Negishi
Drug Metabolism and Disposition February 1, 2002, 30 (2) 208-211; DOI: https://doi.org/10.1124/dmd.30.2.208

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Retinoic Acids Repress Constitutive Active Receptor-Mediated Induction by 1,4-bis[2-(3,5-Dichloropyridyloxy)]benzene of theCyp2b10 Gene in Mouse Primary Hepatocytes

Satoru Kakizaki, Sohrab Karami and Masahiko Negishi
Drug Metabolism and Disposition February 1, 2002, 30 (2) 208-211; DOI: https://doi.org/10.1124/dmd.30.2.208
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Results and Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Functional Characterization of 29 CYP4F2 Variants
  • Exposure-toxicity relation of apatinib
  • ABC phenomenon potentiates anti-HCC efficacy
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics